bal fluid total protein Search Results


amniotic fluid concentration of sp-a, sp-b, sp-d and total protein  (Hutzel Hospital)
90
Hutzel Hospital amniotic fluid concentration of sp-a, sp-b, sp-d and total protein
Amniotic Fluid Concentration Of Sp A, Sp B, Sp D And Total Protein, supplied by Hutzel Hospital, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/amniotic fluid concentration of sp-a, sp-b, sp-d and total protein/product/Hutzel Hospital
Average 90 stars, based on 1 article reviews
amniotic fluid concentration of sp-a, sp-b, sp-d and total protein - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
searchlight protein array multiplex of cell-free supernatant of the bal fluids  (Aushon Biosystems)
90
Aushon Biosystems searchlight protein array multiplex of cell-free supernatant of the bal fluids
Increases in MMPs, inflammatory cells, and cytokines and decrease in alveolar elastin are associated with TSC2-null lung lesion growth. (A to C) MMP expression assessed in the cell-free supernatant of the <t>BAL</t> fluid at the indicated time points. <t>A</t> <t>multiplex</t> assay was performed by Searchlight technology (Aushon Biosystems). Data are means ± SE of n = 11 in each group. ***P < 0.001 for days 15 and 20 versus day 0 by ANOVA (Bonferroni-Dunn). (D) Schematic representation of elastin and collagen disposition in the alveolar neck. (E) Volumes of elastin (Eln) and collagen (Col) in alveoli of Control and TSC2-null lesion–carrying mice. Elastin and collagen were analyzed in alveoli necks of vehicle-injected (Contr) and TSC2-null cell–injected (TSC2-null) mice and expressed as percentage of the total volume of the alveolar neck. Data are means ± SE. **P < 0.01 for Control versus TSC2-null lesion–carrying mice by ANOVA (Bonferroni-Dunn). (F and G) Representative images of alveoli necks of vehicle-injected (Control) (F) and TSC2-null cell–injected (TSC2-null) (G) mice. Verhoeff's elastin stain and Picro-Ponceau counterstain were used to detect elastin (black) and collagen (red), respectively. Arrowheads, elastin-enriched areas. Scale bar, 10 μm. (H to L) Proinflammatory cytokine and chemokine expression assessed with a multiplex assay in the cell-free supernatant of BAL fluid from mice at the indicated time points after tumor inoculation. (M) Inflammatory cell counts assessed from the BAL collected at times as indicated after tumor cell inoculation. Data are means ± SE of n = 11 in each group. *P < 0.05; **P < 0.01; ***P < 0.001 versus day 0 by ANOVA (Bonferroni-Dunn).
Searchlight Protein Array Multiplex Of Cell Free Supernatant Of The Bal Fluids, supplied by Aushon Biosystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/searchlight protein array multiplex of cell-free supernatant of the bal fluids/product/Aushon Biosystems
Average 90 stars, based on 1 article reviews
searchlight protein array multiplex of cell-free supernatant of the bal fluids - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
bal fluid proteins  (Biogen Inc)
90
Biogen Inc bal fluid proteins
Increases in MMPs, inflammatory cells, and cytokines and decrease in alveolar elastin are associated with TSC2-null lung lesion growth. (A to C) MMP expression assessed in the cell-free supernatant of the <t>BAL</t> fluid at the indicated time points. <t>A</t> <t>multiplex</t> assay was performed by Searchlight technology (Aushon Biosystems). Data are means ± SE of n = 11 in each group. ***P < 0.001 for days 15 and 20 versus day 0 by ANOVA (Bonferroni-Dunn). (D) Schematic representation of elastin and collagen disposition in the alveolar neck. (E) Volumes of elastin (Eln) and collagen (Col) in alveoli of Control and TSC2-null lesion–carrying mice. Elastin and collagen were analyzed in alveoli necks of vehicle-injected (Contr) and TSC2-null cell–injected (TSC2-null) mice and expressed as percentage of the total volume of the alveolar neck. Data are means ± SE. **P < 0.01 for Control versus TSC2-null lesion–carrying mice by ANOVA (Bonferroni-Dunn). (F and G) Representative images of alveoli necks of vehicle-injected (Control) (F) and TSC2-null cell–injected (TSC2-null) (G) mice. Verhoeff's elastin stain and Picro-Ponceau counterstain were used to detect elastin (black) and collagen (red), respectively. Arrowheads, elastin-enriched areas. Scale bar, 10 μm. (H to L) Proinflammatory cytokine and chemokine expression assessed with a multiplex assay in the cell-free supernatant of BAL fluid from mice at the indicated time points after tumor inoculation. (M) Inflammatory cell counts assessed from the BAL collected at times as indicated after tumor cell inoculation. Data are means ± SE of n = 11 in each group. *P < 0.05; **P < 0.01; ***P < 0.001 versus day 0 by ANOVA (Bonferroni-Dunn).
Bal Fluid Proteins, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bal fluid proteins/product/Biogen Inc
Average 90 stars, based on 1 article reviews
bal fluid proteins - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Increases in MMPs, inflammatory cells, and cytokines and decrease in alveolar elastin are associated with TSC2-null lung lesion growth. (A to C) MMP expression assessed in the cell-free supernatant of the BAL fluid at the indicated time points. A multiplex assay was performed by Searchlight technology (Aushon Biosystems). Data are means ± SE of n = 11 in each group. ***P < 0.001 for days 15 and 20 versus day 0 by ANOVA (Bonferroni-Dunn). (D) Schematic representation of elastin and collagen disposition in the alveolar neck. (E) Volumes of elastin (Eln) and collagen (Col) in alveoli of Control and TSC2-null lesion–carrying mice. Elastin and collagen were analyzed in alveoli necks of vehicle-injected (Contr) and TSC2-null cell–injected (TSC2-null) mice and expressed as percentage of the total volume of the alveolar neck. Data are means ± SE. **P < 0.01 for Control versus TSC2-null lesion–carrying mice by ANOVA (Bonferroni-Dunn). (F and G) Representative images of alveoli necks of vehicle-injected (Control) (F) and TSC2-null cell–injected (TSC2-null) (G) mice. Verhoeff's elastin stain and Picro-Ponceau counterstain were used to detect elastin (black) and collagen (red), respectively. Arrowheads, elastin-enriched areas. Scale bar, 10 μm. (H to L) Proinflammatory cytokine and chemokine expression assessed with a multiplex assay in the cell-free supernatant of BAL fluid from mice at the indicated time points after tumor inoculation. (M) Inflammatory cell counts assessed from the BAL collected at times as indicated after tumor cell inoculation. Data are means ± SE of n = 11 in each group. *P < 0.05; **P < 0.01; ***P < 0.001 versus day 0 by ANOVA (Bonferroni-Dunn).

Journal: Science translational medicine

Article Title: Prevention of Alveolar Destruction and Airspace Enlargement in a Mouse Model of Pulmonary Lymphangioleiomyomatosis (LAM)

doi: 10.1126/scitranslmed.3003840

Figure Lengend Snippet: Increases in MMPs, inflammatory cells, and cytokines and decrease in alveolar elastin are associated with TSC2-null lung lesion growth. (A to C) MMP expression assessed in the cell-free supernatant of the BAL fluid at the indicated time points. A multiplex assay was performed by Searchlight technology (Aushon Biosystems). Data are means ± SE of n = 11 in each group. ***P < 0.001 for days 15 and 20 versus day 0 by ANOVA (Bonferroni-Dunn). (D) Schematic representation of elastin and collagen disposition in the alveolar neck. (E) Volumes of elastin (Eln) and collagen (Col) in alveoli of Control and TSC2-null lesion–carrying mice. Elastin and collagen were analyzed in alveoli necks of vehicle-injected (Contr) and TSC2-null cell–injected (TSC2-null) mice and expressed as percentage of the total volume of the alveolar neck. Data are means ± SE. **P < 0.01 for Control versus TSC2-null lesion–carrying mice by ANOVA (Bonferroni-Dunn). (F and G) Representative images of alveoli necks of vehicle-injected (Control) (F) and TSC2-null cell–injected (TSC2-null) (G) mice. Verhoeff's elastin stain and Picro-Ponceau counterstain were used to detect elastin (black) and collagen (red), respectively. Arrowheads, elastin-enriched areas. Scale bar, 10 μm. (H to L) Proinflammatory cytokine and chemokine expression assessed with a multiplex assay in the cell-free supernatant of BAL fluid from mice at the indicated time points after tumor inoculation. (M) Inflammatory cell counts assessed from the BAL collected at times as indicated after tumor cell inoculation. Data are means ± SE of n = 11 in each group. *P < 0.05; **P < 0.01; ***P < 0.001 versus day 0 by ANOVA (Bonferroni-Dunn).

Article Snippet: ELISA was performed with a Searchlight Protein Array multiplex of cell-free supernatant of the BAL fluids at Aushon Biosystems.

Techniques: Expressing, Multiplex Assay, Injection, Staining

Rapamycin plus simvastatin rescues animal survival, prevents lesion growth and lung destruction, and abrogates MMP induction. Mice injected with diluent (Control) or TSC2-null cells were treated with vehicle, rapamycin (Rapa), simvastatin (Simva), and rapamycin + simvastatin (Rapa + Simva) from day 3 after injection. (A) Weight of control (black) and TSC2-null cell–injected (red) mice were examined from day 3 (arrows) to day 20 of experiment. Data are means ± SE of n > 5 in each group. *P < 0.01 for Control versus TSC2-null cell–injected mice by ANOVA (Bonferroni-Dunn). Arrows, beginning of treatment. (B to D) H&E staining of murine lungs. Scale bar, 500 μm. (B) Lesion/lung ratio (C) and MAAA analysis (D) were performed at day 20 after injection. Data are means ± SE of n > 8 in each group. **P < 0.001 for Control versus TSC2-null cell–injected vehicle-treated mice and for Rapa, Simva, and Rapa + Simva versus vehicle for TSC2-null cell–injected mice by ANOVA (Bonferroni-Dunn). (E to G) Expression of MMP-2 (E), MMP-3 (F), and MMP-9 (G), assessed in the cell-free supernatant of BAL at day 20 by multiplex assay. Data are means ± SE of n > 6 in each group. **P < 0.001 for compound- versus vehicle-treated mice by ANOVA (Bonferroni-Dunn).

Journal: Science translational medicine

Article Title: Prevention of Alveolar Destruction and Airspace Enlargement in a Mouse Model of Pulmonary Lymphangioleiomyomatosis (LAM)

doi: 10.1126/scitranslmed.3003840

Figure Lengend Snippet: Rapamycin plus simvastatin rescues animal survival, prevents lesion growth and lung destruction, and abrogates MMP induction. Mice injected with diluent (Control) or TSC2-null cells were treated with vehicle, rapamycin (Rapa), simvastatin (Simva), and rapamycin + simvastatin (Rapa + Simva) from day 3 after injection. (A) Weight of control (black) and TSC2-null cell–injected (red) mice were examined from day 3 (arrows) to day 20 of experiment. Data are means ± SE of n > 5 in each group. *P < 0.01 for Control versus TSC2-null cell–injected mice by ANOVA (Bonferroni-Dunn). Arrows, beginning of treatment. (B to D) H&E staining of murine lungs. Scale bar, 500 μm. (B) Lesion/lung ratio (C) and MAAA analysis (D) were performed at day 20 after injection. Data are means ± SE of n > 8 in each group. **P < 0.001 for Control versus TSC2-null cell–injected vehicle-treated mice and for Rapa, Simva, and Rapa + Simva versus vehicle for TSC2-null cell–injected mice by ANOVA (Bonferroni-Dunn). (E to G) Expression of MMP-2 (E), MMP-3 (F), and MMP-9 (G), assessed in the cell-free supernatant of BAL at day 20 by multiplex assay. Data are means ± SE of n > 6 in each group. **P < 0.001 for compound- versus vehicle-treated mice by ANOVA (Bonferroni-Dunn).

Article Snippet: ELISA was performed with a Searchlight Protein Array multiplex of cell-free supernatant of the BAL fluids at Aushon Biosystems.

Techniques: Injection, Staining, Expressing, Multiplex Assay